- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Shilpa Medicare Limited — Updates, 06-02-2026: General Updates
06-02-2026 | 07:00 pm
06-02-2026 | 07:00 pm
Shilpa Medicare filed its first transdermal patch ANDA for Rotigotine (Parkinson's/RLS) with USFDA. This marks a significant milestone, targeting a US market estimated at $112 million (~929.6 Cr).
No comments yet. Be the first to comment!